Airway inflammatory markers in chronic obstructive pulmonary disease patients and healthy smokers

Nigerian Journal of Clinical Practice

Volumn 16, Issue 1, 2013, Pages 76-81

  Hacievliyagil, S S ^a   Mutlu, L C ^b   Temel, I ^a  

^a INONU UNIVERSITY   (Turkey)

^b NAMIK KEMAL UNIVERSITY   (Turkey)

Author keywords

Chronic obstructive pulmonary disease; IL 6; IL 8; Induced sputum; Inflammatory markers; TNF

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHEMISTRY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; SMOKING; SPUTUM;

BIOLOGICAL MARKERS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPUTUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873669995     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: 10.4103/1119-3077.106771     Document Type: Article

References (20)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Guidelines: Workshop report. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available from: http://www.goldcopd.com. Updated 2003, 2006, 2008 and 2011. [Last Accessed on 2011 Nov 2011].
2. Chung KF. Cytokines. In: Barnes PJ, Drazen JM, Rennard S, Thomson NC, editors. Asthma and COPD: Basic mechanisms and clinical management. London: Academic Press; 2002. p. 261-71.
3. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J 2001;34:50-9.
4. Garcia-Rio F, Miravitlles M, Soriano JB, Muñoz L, Duran-Tauleria E, Sánchez G, et al. Systemic infammation in chronic obstructive pulmonary disease: A population-based study. Respir Res 2010;11:63.
5. Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000;55:114-20.
6. Aaron SD, Angel JB, Lunau M, Wright K, Fex C, Le Saux N, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:349-55.
7. Hacievliyagil SS, Gunen H, Mutlu LC, Karabulut AB, Temel I. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Respir Med 2006;100:846-54.
8. Bhowmik A, Seemungal TA, Sapsford RJ, Devalia JL, Wedzicha JA. Comparison of spontaneous and induced sputum for investigation of airway infammation in chronic obstructive pulmonary disease. Thorax 1998;53:953-6.
9. Roland M, Bhowmik A, Sapsford RJ, Seemungal TA, Jeffries DJ, Warner TD, et al. Sputum and plasma endotelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax 2001;56:30-5.
10. Wright JL, Lawson LM, Pare PD, Wiggs BJ, Kennedy S, Hogg JC. Morphology of peripheral airways in current smokers and ex-smokers. Am Rev Respir Dis 1983;127:474-7.
11. Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis 1983;128:833-8.
12. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-a in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;153:530-4.
13. Masubuchi T, Koyama S, Sato E, Takamizawa A, Kubo K, Sekiguchi M, et al. Smoke extract stimulates lung epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Pathol 1998;153:1903-12.
14. Mio T, Romberger DJ, Thompson AB, Robbins RA, Heires A, Rennard SI. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med 1997;155:1770-6.
15. Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M, et al. Increased expression of infammatory mediators in small-airway epithelium from tobacco smokers. Am J Physiol Lung Cell Mol Physiol 2000;278:L906-13.
16. Wang S, Xu F, Chen Y. Detection and signifcance of interleukin-8, 6, tumor necrosis factor-alpha in sputa from patients with chronic obstructive pulmonary disease. Zhonghua Jie He He Hu Xi Za Zhi 2000;23:465-7. (abstract-PMID: 11778258).
17. Yamamoto C, Yoneda T, Yoshikawa M, Fu A, Tokuyama T, Tsukaguchi K, et al. Airway infammation in COPD assessed by sputum levels of interleukin-8. Chest 1997;112:505-10.
18. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. Airway infammation and bronchial microbial patterns in patients with stable COPD. Eur Respir J 1999;14:1015-22.
19. Kanazawa H, Kurihara N, Otsuka T, Fujii T, Tanaka S, Kudoh S, et al. Clinical signifcance of serum concentration of interleukin 8 in patients with bronchial asthma or chronic pulmonary emphysema. Respiration 1996;63:236-40.
20. Wang F, He B. The effect of dithiothreitol on chemotactic factors in induced sputum of chronic obstructive pulmonary disease patients. Respiration 2009;78:217-22.